Clinical Analytics Market

The report "Clinical Analytics Market by Offering (Raw Data, Platform), Source (EHR, Trials, Claims, RWE), Use Case (CDSS, RPM, PHM, R&D, Pharmacovigilance, Precision Medicine, Regulatory), End User (Hospital, Payer, Pharma, Medtech), Region - Global Forecast to 2030", is expected to grow to USD 81.32 billion by 2030 from USD 33.09 billion in 2025, at a CAGR of 19.7% during the forecast period of 2025 to 2030.

Browse 400 market data Tables and 50 Figures spread through 400 Pages and in-depth TOC on "Clinical Analytics Market by Offering (Raw Data, Platform), Source (EHR, Trials, Claims, RWE), Use Case (CDSS, RPM, PHM, R&D, Pharmacovigilance, Precision Medicine, Regulatory), End User (Hospital, Payer, Pharma, Medtech), Region - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/clinical-analytics-market-21358684.html

The growth of the clinical analytics market is driven by the integration of social determinants of health (SDoH) data, enabling a deeper understanding of factors influencing patient outcomes beyond traditional clinical metrics. Healthcare providers and payers are increasingly using these insights to address disparities and improve population health management. At the same time, the development of interoperable AI algorithms capable of analyzing multi-modal datasets—including imaging, genomics, and real-world evidence (RWE) is expanding the scope of analytics in precision medicine and personalized care. The digitization of clinical trials and the rise of decentralized and hybrid trial models are also fueling demand for advanced analytics to streamline data collection, enhance participant monitoring, and accelerate research timelines. Moreover, the growing use of RWE in drug development and post-market surveillance is driving pharmaceutical companies and regulators to adopt robust analytics platforms that support evidence-based decision-making, strengthening innovation and improving patient outcomes.

Based on use case, the healthcare segment accounted for a significant market share in the clinical analytics market in 2024.

The healthcare use case segment accounted for significant growth in the clinical analytics market in 2024, driven by the increasing adoption of value-based care models and the growing demand for data-driven decision-making to improve patient outcomes. Healthcare providers are leveraging clinical analytics for clinical decision support, population health management, remote patient monitoring, and operational efficiency enhancement. The rising prevalence of chronic diseases, aging populations, and higher patient volumes are further accelerating the need for advanced analytics to predict disease trends, optimize resource allocation, and reduce readmissions and healthcare costs. Additionally, the integration of analytics with EHR systems, AI, and telehealth platforms is enabling real-time insights, personalized care plans, and improved quality reporting, reinforcing the segment’s strong growth trajectory.

Based on end users, the healthcare provider segment registered the fastest growth in the clinical analytics market for the forecasted period.

A key driver for the significant growth of the healthcare providers segment in the clinical analytics market is the increasing need to improve patient outcomes, reduce costs, and optimize operational efficiency through real-time, data-driven decision-making. Healthcare providers generate the majority of clinical data from EHRs, diagnostic imaging, laboratory systems, and connected medical devices, creating a strong foundation for analytics adoption. As value-based care models gain traction globally, providers are under growing pressure to demonstrate measurable improvements in quality of care and operational performance. This growth is fueled using predictive analytics to identify high-risk patients, optimize resource allocation, and support proactive interventions that reduce readmission rates and complications. Moreover, real-time insights enable hospitals and health systems to streamline workflows, reduce waste, and enhance care coordination, making clinical analytics an indispensable tool in modern healthcare delivery.

North America dominated the clinical analytics market in 2024.

North America dominated the clinical analytics market in 2024, driven by its highly digitized healthcare ecosystem, significant investments in healthcare IT infrastructure, and the widespread adoption of electronic health records (EHRs). The United States, in particular, benefits from a strong regulatory framework promoting data-driven care models and value-based reimbursement programs, encouraging healthcare providers and payers to leverage advanced analytics for improving outcomes and reducing costs. A mature network of health IT vendors, academic research centers, and pharmaceutical companies has further accelerated innovation in areas such as precision medicine, population health management, and clinical decision support. Rising chronic disease prevalence, coupled with the growing demand for real-world evidence (RWE) and digitized clinical trials, has fuelled analytics adoption across hospitals, payer networks, and life sciences organizations, solidifying North America's position as the global leader in the clinical analytics market.

The report profiles key players such Optum, Inc. (UnitedHealth Group) (US), Merative (US), Epic Systems Corporation (US), GE HealthCare (US), Siemens Healthineers (Germany), Oracle Health Sciences (US), McKesson Corporation (US), Veradigm LLC (US), IQVIA (US), Cotiviti Inc. (US), Health Catalyst (US), Cognizant (US), Koninklijke Philips N.V. (Netherlands), Dassault Systèmes (France), Athenahealth, Inc. (US), Veeva Systems (US), ICON plc (Ireland), eClinicalWorks (US), Accenture (Ireland), CVS Health (US), Inovalon (US), WNS (Holdings) Ltd. (UK), SOPHiA GENETICS (Switzerland), F. Hoffmann-La Roche Ltd (Roche)(FLATIRON HEALTH) (US), SAS Institute, Inc. (US).

Don’t miss out on business opportunities in Clinical Analytics Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/